Statistics
Publications
2
Citations
121
H-Index
2
Active since
2016
Dong-Wan Kim is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and combination immunotherapy.
Publications per year
2016–2025
2
2
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer
Alison M. Schram, Kōichi Goto, Dong-Wan Kim et al. · New England Journal of Medicine · 2025 · 104 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +16
1–2 of 2